Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 5Venous Thrombosis 4Neoplasms 4Pulmonary Embolism 3Thrombosis 1Thromboembolism 1Pancreatic Neoplasms 1Obesity 1Multiple Myeloma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Gemcitabine 1Fondaparinux 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thromboembolism × Dalteparin × Clear all
NCT00031837 2015-10-14

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

University of Rochester

Phase 3 Terminated
400 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡